For Healthcare Professionals

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

clipboard-pencil

About the study

The purpose of this study is to evaluate BMS-986315 alone and in combination with nivolumab or cetuximab in participants with advanced solid tumors.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

  1. Participants must have histologic confirmation of advanced (metastatic, recurrent, and/or unresectable) squamous cell carcinoma of the head and neck (SCCHN), nonsmall cell lung cancer (NSCLC), or renal cell cancer (RCC) with measurable disease per RECIST 1.1
  2. Participants expected to have received standard of care therapies including an available PD-(L)1 inhibitor
  3. Eastern cooperative oncology group performance status of 0 or 1
  4. Women of childbearing potential must agree to follow methods of contraception

EXCLUSION CRITERIA

  1. Participants with active, known or suspected autoimmune disease
  2. Participants with a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications
  3. Uncontrolled or significant cardiovascular disease
  4. History of or with active interstitial lung disease or pulmonary fibrosis
  5. Prior participation in anti-natural killer cell receptor (anti-NKG2A) clinical study
  6. History of allergy or hypersensitivity to study drug components Other protocol-defined inclusion/exclusion criteria apply
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall 855-907-3286Email iconEmail Study Center

Study’s details


Contition

Advanced Solid Tumor

Age (in years)

18 - 200

Phase

Phase 1/Phase 2

Participants needed

308

Est. Completion Date

May 2025

Treatment type

Interventional


Sponsor

Bristol-Myers Squibb

ClinicalTrials.gov identifier

NCT04349267

Study number

CA047004

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.